TrialVascular health and risk management2013

Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.

G D Radchenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.